首页> 外文OA文献 >PCN69 Cost of Treatment of Radiopharmaceutical and Chemotherapy for the Treatment of Castration-Resistant Prostate Cancer With Bone Metastases In Hospital Setting

【2h】

PCN69 Cost of Treatment of Radiopharmaceutical and Chemotherapy for the Treatment of Castration-Resistant Prostate Cancer With Bone Metastases In Hospital Setting

机译：PCN69放射治疗和化学疗法在医院环境中治疗去势抵抗性前列腺癌并伴骨转移的治疗费用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wen L.; Valderrama A.; Carlton R.; Eaddy M.; Seal B.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A COST COMPARISON OF TREATMENT WITH ABIRATERONE ACETATE PLUS PREDNISONE IN THE PRE-CHEMOTHERAPY SETTING FOLLOWED BY ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING VERSUS THE OPPOSITE TREATMENT SEQUENCE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS WITH NON-VISCERAL METASTASES IN COLOMBIA [J] . Gamboa O., Bonilla C., Varela R. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：在化疗预疗法中，在化疗预疗法中的丙酸盐加上泼尼松治疗的成本比较，然后在化疗后的依齐甲酰胺与哥伦比亚非内脏转移患者的转移阉割前列腺癌患者相反的治疗序列
2. Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data. [J] . Charles J Ryan, Philip J Saylor, Jason J Everly, The oncologist . 2014,第10期

机译：靶向骨的放射性药物治疗骨转移去势抵抗性前列腺癌：探索新数据的意义。
3. Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data [J] . Charles J. Ryan, Jason J. Everly, Oliver Sartor, The oncologist . 2014,第10期

机译：靶向骨的放射性药物治疗抗转移性去势的前列腺癌：探索新数据的含义
4. Enhancing chemotherapy by ultrasound and microbubbles: Effect of acoustic pressure and treatment order in in vitro suspension of reast and prostate cancer cells [C] . Karshafian Raffi, Almasri Firas, Giles Anoja, 2010 IEEE International Ultrasonics Symposium . 2010

机译：通过超声和微气泡增强化学疗法：声压和治疗顺序对离体和前列腺癌细胞体外悬浮的影响
5. Determination of novel metabolites of therapeutic agents used in the treatment of castration-resistant prostate cancer. [D] . Alyamani, Mohammad. 2017

机译：测定用于去势抵抗性前列腺癌的治疗剂的新代谢产物。
6. Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data [O] . Charles J. Ryan, Philip J. Saylor, Jason J. Everly, 2014

机译：靶向骨的放射性药物治疗抗转移性去势的前列腺癌：探索新数据的含义
7. PCN93 A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases [O] . Dearden L, Girod I, Majer I, 2015

机译：PCN93在化疗前环境中使用醋酸阿比特龙+泼尼松治疗，化疗后环境中使用恩扎鲁胺治疗与转移性去势抵抗性前列腺癌非内脏转移患者相反治疗顺序的成本比较

PCN69 Cost of Treatment of Radiopharmaceutical and Chemotherapy for the Treatment of Castration-Resistant Prostate Cancer With Bone Metastases In Hospital Setting

著录项

引文网络

相似文献

相关主题

期刊订阅